Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rochester, NY
NPI
1639576622
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
224 Alexander St Ste 200
Rochester, NY, 14607
Phone (585) 922-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$84K
3,384 services
Medicare patients, 2024
270
Average age 67
Drug cost, 2024
$3.8M
7,148 prescriptions
Company payments, 2025
$1,654
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luis F Chavez was code J0897 (injection, denosumab, 1 mg), 1,740 times for 16 patients. In total Luis F Chavez billed 3,384 services in 16 codes, and Medicare paid $84K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,740 | 16 | $20.39 | $35K |
| 99214 Office E&M - Established | Office | 330 | 202 | $77.00 | $25K |
| 95251 Test - Miscellaneous | Office | 51 | 32 | $24.81 | $1,266 |
| 99204 Office E&M - New | Office | 50 | 50 | $117.23 | $5,861 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 50 | 41 | $13.32 | $666 |
| 96372 Injection Administration | Office | 44 | 19 | $10.50 | $462 |
| 83036 Blood Count | Office | 19 | 18 | $9.52 | $181 |
| 99223 Hospital E&M - Initial | Facility | 15 | 14 | $139.06 | $2,086 |
By year: 2022 $86K for 3,952 services; 2023 $79K for 3,000 services; 2024 $84K for 3,384 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 19 | 18 | $9.52 | $181 |
Medicare prescription drug claims, 2024
In 2024, the drug Luis F Chavez prescribed most often to Medicare patients was Ozempic (Semaglutide), with 772 prescriptions and refills. In total Luis F Chavez wrote 7,148 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 772 | 1,178 | 180 | $1.1M |
| Levothyroxine Sodium Generic | 656 | 1,649 | 189 | $9,635 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 530 | 1,160 | 173 | $67K |
| Trulicity Dulaglutide | 434 | 613 | 111 | $590K |
| Mounjaro Tirzepatide | 373 | 422 | 76 | $444K |
| Jardiance Empagliflozin | 369 | 769 | 105 | $433K |
| Metformin Hcl Generic | 355 | 921 | 116 | $3,465 |
| Metformin Hcl Er Metformin Hcl | 280 | 650 | 82 | $4,060 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 236 | 416 | 83 | $62K |
| Atorvastatin Calcium Generic | 183 | 517 | 67 | $2,452 |
| Glimepiride Generic | 149 | 369 | 52 | $1,543 |
| Glipizide Generic | 148 | 359 | 47 | $1,145 |
| Methimazole Generic | 125 | 289 | 28 | $1,206 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 123 | 262 | 44 | $13K |
| Farxiga Dapagliflozin Propanediol | 122 | 201 | 31 | $112K |
Brand drugs: 4,137 claims; generic drugs: 2,471 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luis F Chavez $1,654 ($1,654 in general payments such as food, travel and fees) from 8 companies. The largest payer was Novo Nordisk Inc with $454.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.